Targeted disruption of stat6 DNA binding activity by an oligonucleotide decoy blocks IL-4-driven T(H)2 cell response.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Blood

• Publication date

  2000-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V95.4.1249.004K39_1249_1257PMID 10666197
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dual Blockade of Cyclic AMP Response Element- (CRE) and AP-1-directed Transcription by CRE-transcription Factor Decoy Oligonucleotide

  1999cited by this paper
• Activation of STAT proteins and cytokine genes in human Th1 and Th2 cells generated in the absence of IL-12 and IL-4.

  1998cited by this paper
• In vivo IL-4 responses to anti-IgD antibody are MHC class II dependent and beta 2-microglobulin independent and develop normally in the absence of IL-4 priming of T cells.

  1998cited by this paper
• Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA.

  1998cited by this paper
• Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo.

  1998cited by this paper
• JAK/STAT signaling by cytokine receptors.

  1998cited by this paper
• An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro.

  1998cited by this paper
• Th1/Th2 balance in human disease.

  1998cited by this paper
• STAT6 is required for IL-4-induced germline Ig gene transcription and switch recombination.

  1998cited by this paper
• Stat6 inhibits human interleukin-4 promoter activity in T cells.

  1998cited by this paper
• Long-range transcriptional regulation of cytokine gene expression.

  1998cited by this paper
• Identification of Cis-elements of the Human Endothelin-A Receptor Gene and Inhibition of the Gene Expression by the Decoy Strategy*

  1998cited by this paper
• The role of helper T cell subsets in autoimmune diseases.

  1998cited by this paper
• Abrogation of Bronchial Eosinophilic Inflammation and Airway Hyperreactivity in Signal Transducers and Activators of Transcription (STAT)6-deficient Mice

  1998cited by this paper
• Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease.

  1998cited by this paper
• Genes that regulate interleukin-4 expression in T cells.

  1997cited by this paper
• Roles of IL-4 and IFN-gamma in stabilizing the T helper cell type 1 and 2 phenotype.

  1997cited by this paper
• Th1 and Th2 CD4+ Cells in the Pathogenesis of Allergic Diseases

  1997cited by this paper
• Oligonucleotide therapeutics — Novel cardiovascular targets

  1997cited by this paper
• The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells.

  1997cited by this paper
• Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality.

  1997cited by this paper
• In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction

  1997cited by this paper
• STAT6: its role in interleukin 4-mediated biological functions

  1997cited by this paper
• Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice.

  1997cited by this paper
• A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFkappaB binding site: evidence for a role of NFkappaB in ischemia-reperfusion injury.

  1997cited by this paper
• IL-4 and IL-13 production in differentiated T helper type 2 cells is not IL-4 dependent.

  1997cited by this paper
• A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFkB binding site : Evidence for a role of NFkB in ischemia-reperfusion injury. Commentary

  1997cited by this paper
• Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted State6 gene

  1996cited by this paper
• Role of transcriptional cis-elements, angiotensinogen gene-activating elements, of angiotensinogen gene in blood pressure regulation.

  1996cited by this paper
• Requirements for interleukin-4-induced gene expression and functional characterization of Stat6

  1996cited by this paper
• Stat6 is required for mediating responses to IL-4 and for development of Th2 cells.

  1996cited by this paper
• Transcription factor decoy approach to decipher the role of NF-kappa B in oncogenesis.

  1996cited by this paper
• The expanding universe of T-cell subsets: Th1, Th2 and more.

  1996influential reference
• Cytokine transcriptional events during helper T cell subset differentiation

  1996cited by this paper
• The NF-kappaB transcription factor in oncogenesis.

  1996cited by this paper
• Essential role of Stat6 in IL-4 signalling

  1996cited by this paper
• The regulation of the development of CD8 effector T cells.

  1996cited by this paper
• In vivo gene transfer and gene modulation in hypertension research.

  1996cited by this paper
• Type 1 and type 2: a fundamental dichotomy for all T-cell subsets.

  1996influential reference
• Embryonic development and pattern formation

  1996cited by this paper
• Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain.

  1995cited by this paper
• Effect of phosphodiesterase inhibition on IL-4 and IL-5 production of the murine TH2-type T cell clone D10.G4.1.

  1995cited by this paper
• Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice.

  1995cited by this paper
• Transient decrease in high blood pressure by in vivo transfer of antisense oligodeoxynucleotides against rat angiotensinogen.

  1995cited by this paper
• Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines.

  1995cited by this paper
• A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.

  1995cited by this paper
• Regulation of the development of type 2 T-helper cells in allergy.

  1994cited by this paper
• Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response.

  1994cited by this paper
• An interleukin-4-induced transcription factor: IL-4 Stat.

  1994cited by this paper
• CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3

  1994cited by this paper
• A common nuclear signal transduction pathway activated by growth factor and cytokine receptors.

  1993cited by this paper
• Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4.

  1993cited by this paper
• Generation and analysis of interleukin-4 deficient mice.

  1991cited by this paper
• Regulation of gene expression with double-stranded phosphorothioate oligonucleotides.

  1990cited by this paper
• The SIF binding element confers sis/PDGF inducibility onto the c‐fos promoter.

  1990cited by this paper
• Phosphate-methylated DNA aimed at HIV-1 RNA loops and integrated DNA inhibits viral infectivity.

  1990cited by this paper
• Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication.

  1990cited by this paper
• Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus.

  1988cited by this paper
• Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.

  1987cited by this paper
• B-cell stimulatory factor-1/interleukin 4.

  1987cited by this paper

• Decoy oligodeoxynucleotides targeting STATs in non-cancer gene therapy.

  2025cites this paper
• Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment

  2024cites this paper
• STAT6 decoy oligodeoxynucleotide (ODN)-containing ointment more potently inhibits mouse skin inflammation when formulated with ionic liquid technology than as a traditional Vaseline ointment.

  2019cites this paper
• STAT3 as a Major Contributor to Chemoresistance

  2019cites this paper
• The fungal metabolite cyclonerodiol inhibits IL‐4/IL‐13 induced Stat6‐signaling through blocking the association of Stat6 with p38, ERK1/2 and p300

  2018cites this paper
• Regulation of monoamine oxidase A (MAO-A) expression, activity, and function in IL-13–stimulated monocytes and A549 lung carcinoma cells

  2018cites this paper
• A Two-Photon-Photocleavable Linker for Triggering Light-Induced Strand Breaks in Oligonucleotides.

  2017cites this paper
• Retraction Retracted : A Role for PPAR γ in the Regulation of Cytokines in Immune Cells and Cancer PPAR Research

  2017cites this paper
• Targeting the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 6 (STAT6) with Cell-Permeable, Phosphatase-Stable Phosphopeptide Mimics Potently Inhibits Tyr641 Phosphorylation and Transcriptional Activity.

  2015cites this paper
• A hypothesis-effect of T cell epitope fusion peptide specific immunotherapy on signal transduction.

  2015cites this paper
• Regulation of Gene Expression through Photocaged Oligonucleotides.

  2013cites this paper
• IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages.

  2013cites this paper
• Jak/STAT Signaling in the Pathogenesis and Treatment of Multiple Myeloma

  2013cites this paper
• From Macrophage Interleukin-13 Receptor to Foam Cell Formation

  2012cites this paper
• Signaling Pathways in Cancer Pathogenesis and Therapy

  2012cites this paper
• Photochemical control of DNA decoy function enables precise regulation of nuclear factor κB activity.

  2011cites this paper
• Targeting STAT6 in Atopic Eczema/Dermatitis

  2010cites this paper
• Targeting allergic airway diseases by siRNA: an option for the future?

  2009cites this paper
• Preparation of goat milk anti-Saccharomyces ce21eVisiae immunoglobulin

  2009cites this paper
• Saccharomyces cerevisiae に対するヤギ乳 IgG 画分の調製とその酵母と IgG 画分を経口摂取したマウスの免疫機能

  2009cites this paper
• A Role for PPARγ in the Regulation of Cytokines in Immune Cells and Cancer

  2008cites this paper
• Entwicklung einer therapeutischen Strategie bei Allergie und Asthma unter Einsatz von Ribozymen und DNAzymen

  2008cites this paper
• Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivo

  2008cites this paper
• Primary Prevention of Allergic Diseases: Current Concepts and Mechanisms

  2007cites this paper
• Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice

  2007cites this paper
• Polymorphisms of CUL5 Are Associated with CD4+ T Cell Loss in HIV-1 Infected Individuals

  2007cites this paper
• A review of antisense therapeutic interventions for molecular biological targets in asthma

  2007cites this paper
• STAT3-decoy oligodeoxynucleotide inhibits the growth of human lung cancer via down-regulating its target genes.

  2007cites this paper
• A Role for Dietary Selenium and Selenoproteins in Allergic Airway Inflammation1

  2007influential citation
• INVESTIGATION OF THE MECHANISM AND THERAPEUTIC POTENTIAL OF A TRANSCRIPTION FACTOR DECOY TARGETING SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION-3 (STAT3) FOR SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)

  2007cites this paper
• The role of the STAT6 gene in the IL-4/IL-13 pathway: analyses of polymorphisms, functional studies and their effect on IgE regulation and the development of asthma

  2007cites this paper
• This information is current as Inflammation Selenoproteins in Allergic Airway A Role for Dietary Selenium and

  2007influential citation
• An oligonucleotide decoy for Stat3 activates the immune response of macrophages to breast cancer.

  2006cites this paper
• Targeting transcription: a new concept of anti-inflammatory therapy of airway diseases.

  2006cites this paper
• Treatment of allergic asthma by targeting transcription factors using nucleic-acid based technologies.

  2006cites this paper
• STAT-6-mediated control of P-selectin by substance P and interleukin-4 in human dermal endothelial cells.

  2006cites this paper
• In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy

  2005cites this paper
• The role of IL-6 and STAT3 in inflammation and cancer.

  2005cites this paper
• Immunomodulation: the future of allergy and asthma treatment

  2004cites this paper
• In vivo transfection of a cis element ‘decoy’ against signal transducers and activators of transcription 6 (STAT6)-binding site ameliorates IgE-mediated late-phase reaction in an atopic dermatitis mouse model

  2004cites this paper
• Biological activity and delivery of peptide nucleic acids (PNA)-DNA chimeras for transcription factor decoy (TFD) pharmacotherapy.

  2004cites this paper
• Molecular therapy versus standard treatment in allergy (Review).

  2004cites this paper
• Transcriptional crosstalk between nuclear receptors and cytokine signal transduction pathways in immunity.

  2004cites this paper
• In vivo transfection of a cis element ‘decoy’ against signal transducers and activators of the transcription 6 (STAT6) binding site ameliorates the response of contact hypersensitivity

  2004cites this paper
• New trends in the development of transcription factor decoy (TFD) pharmacotherapy.

  2004cites this paper
• Complexation to Cationic Microspheres of Double-Stranded Peptide Nucleic Acid-DNA Chimeras Exhibiting Decoy Activity

  2004cites this paper
• Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression.

  2004cites this paper
• The role of STATs in inflammation and inflammatory diseases.

  2004cites this paper
• Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth

  2003cites this paper
• Distinct palindromic extensions of the 5’‐TTC…GAA‐3’ motif allow STAT6 binding in vivo

  2003cites this paper
• T helper type 2 cytokine receptors and associated transcription factors GATA-3, c-MAF, and signal transducer and activator of transcription factor-6 in induced sputum of atopic asthmatic patients.

  2003cites this paper
• StAT signaling in cancer: insights into pathogenesis and treatment strategies.

  2003cites this paper
• Transcription Factors: New Targets for Antiallergic Therapy

  2003cites this paper
• Signal transducer and activator of transcription proteins in leukemias.

  2003cites this paper
• Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential

  2003cites this paper
• The cis decoy against the estrogen response element suppresses breast cancer cells via target disrupting c-fos not mitogen-activated protein kinase activity.

  2003cites this paper
• Activation of Peroxisome Proliferator-Activated Receptor γ by Nitric Oxide in Monocytes/Macrophages Down-Regulates p47phox and Attenuates the Respiratory Burst1

  2002cites this paper
• Asthma: future directions.

  2002cites this paper
• Modulation of Th1 and Th2 responses for immunotherapy

  2002cites this paper
• Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.

  2002cites this paper
• Modulation of gene expression in human osteoblasts by targeting a distal promoter region of human estrogen receptor-alpha gene.

  2002cites this paper
• T cells and aging, January 2002 update.

  2002cites this paper
• Transcription Factor Decoy (TFD) in Breast Cancer Research and Treatment

  2002cites this paper
• An LXXLL Motif in the Transactivation Domain of STAT6 Mediates Recruitment of NCoA-1/SRC-1*

  2002cites this paper
• Activation of Estrogen Receptor Blocks Interleukin-6-inducible Cell Growth of Human Multiple Myeloma Involving Molecular Cross-talk between Estrogen Receptor and STAT3 Mediated by Co-regulator PIAS3*

  2001cites this paper
• TH2 cytokine-associated transcription factors in atopic and nonatopic asthma: evidence for differential signal transducer and activator of transcription 6 expression.

  2001cites this paper
• Delayed activation of PPARγ by LPS and IFN-γ attenuates the oxidative burst in macrophages

  2001cites this paper
• [Churg-Strauss syndrome].

  2001cites this paper
• New anti-asthma therapies: suppression of the effect of interleukin (IL)-4 and IL-5.

  2001cites this paper
• Delayed activation of PPARγ by LPS and IFN‐γ attenuates the oxidative burst in macrophages

  2001cites this paper
• Das Churg-Strauss-Syndrom

  2001cites this paper
• Delayed activation of PPARgamma by LPS and IFN-gamma attenuates the oxidative burst in macrophages.

  2001cites this paper
• Integration of TCR and IL-4 signals through STAT6 and the regulation of IL-4 gene expression.

  2000cites this paper
• Interleukins 4 and 13 Increase Intestinal Epithelial Permeability by a Phosphatidylinositol 3-Kinase Pathway

  2000cites this paper
• Superantigen immune stimulation activates epithelial STAT-1 and PI 3-K: PI 3-K regulation of permeability.

  2000cites this paper
• STAT proteins: novel molecular targets for cancer drug discovery

  2000cites this paper
• New immunological approaches and cytokine targets in asthma and allergy.

  2000cites this paper
• Therapeutic applications of transcription factor decoy oligonucleotides.

  2000cites this paper
• STAT Signaling in the Pathogenesis and Treatment of Cancer

  1999cites this paper
• Digital Commons @ East Tennessee State University Digital Commons @ East Tennessee State University

  year unknowncites this paper
• A New Gene Therapy for Pancreatic Cancer: STAT6-CYBB Decoy Oligodeoxynucleotides Focusing on Inhibiting M2 Macrophages

  year unknowncites this paper